Proteomica e metabolomica nello studio della malattia di Alzheimer

Translated title of the contribution: Proteomic and metabolomic approaches in the study of Alzheimer disease (AD)

Francesca Sicilia, Giulia Maria Sancesario, Giorgio Federici

Research output: Contribution to journalArticle

Abstract

Pathophysiologic changes associated with AD begin decades before the appearance of clinical symptoms; it is therefore essential an advancement of the knownledge of the etiopathogenetic process in early stages of disease. Proteomics and metabolomics are powerfull tools for the study and the comprehensive analysis of proteins and low MW compounds in a biological sample. These tools show great potential for the discovery of new biomarkers. Here we analyze recent developments in the application of proteomic and metabolomic technologies for searching new biomarkers for AD.

Translated title of the contributionProteomic and metabolomic approaches in the study of Alzheimer disease (AD)
Original languageItalian
Pages (from-to)198-202
Number of pages5
JournalBiochimica Clinica
Volume38
Issue number3
Publication statusPublished - 2014

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Biochemistry, medical
  • Medical Laboratory Technology

Fingerprint Dive into the research topics of 'Proteomic and metabolomic approaches in the study of Alzheimer disease (AD)'. Together they form a unique fingerprint.

  • Cite this

    Sicilia, F., Sancesario, G. M., & Federici, G. (2014). Proteomica e metabolomica nello studio della malattia di Alzheimer. Biochimica Clinica, 38(3), 198-202.